Barriers against infectious microorganisms.
Bacteria are the microorganisms that most frequently cause infectious diseases in humans. The synthesis of silver nanoparticles (AgNPs) has attracted interest due to the new and different physical and chemical characteristics with applications in new fields. AgNPs, alone or supported on ceramic, are used as antimicrobial fillers in textiles and polymers for food-packaging and biomedical applications, for antimicrobial paints, and potentially for drug delivery. The evaluation of mesoporous nanostructures or nanocomposites as FDU-12/lignin/silver was effective in inhibiting Staphylococcus aureus, E. coli, Enterococcus faecalis, and Candida albicans. The best results were achieved against the inhibition of E. coli and with the structures FDU-12/silver. In plates with FDU-12/lignin/silver, FDU-12, FDU-12/lignin, and the positive control, it was enumerated at 0, 6, 14, and 27 colonies, respectively. While the development of resistance to a new antibiotic is expected, the time course and degree of resistance are uncertain and depend on various factors. The application of AgNPs as nanocomposites can alter the expression of bacterial proteins and could be used for inactivation. This review explores such aspects and a number of factors arising like the use of nanostructures against E. coli, from the knowledge acquired.
- Escherichia coli
- E. coli resistance
Bacterial survival and persistence in an inappropriate substrate can be defined as the ability of bacteria to tolerate exposure to lethal concentrations of bactericidal antibiotics. This view was first noticed in 1944 regarding that treatment of cultures of
Antimicrobial is a general term for drugs, chemicals, and/or other substances that either kill or slow the microbial metabolism. Various antimicrobial agents that are in use today are antibiotic, antiviral, antifungal, and antiparisitic drugs. An antibiotic is a type of antimicrobial agent produced by a fungi or a bacterium that has a direct influence on other microbes, specifically bacteria. Many of antibiotic resistance genes are found on transposons, integrons, and/or plasmids that can be transferred to another bacteria belonging to the same or different species  and resistance elements can be transferred to the human commensal or pathogenic microbiome .
The genes conferring resistance to antibiotics have been widely distributed in the environment since before the introduction of antibiotic chemotherapies, but human activities are probably the major driven force of the resistant bacteria found in air and water, principally with
Studies with animals  showed that the proximity with humans has the tendency to generate more antibiotic-resistant enteric bacteria as saw with African baboons. With birds, a study  showed that 8% of
Antibiotics kill or inhibit bacteria that are susceptible to that antibiotic. Bacteria that are intrinsically resistant or that can acquire resistance will survive and replace the drug-susceptible bacteria. The production of an antibiotic is associated with the presence of genes encoding one or more self-protection processes. Antibiotic biosynthesis gene clusters that encode resistance proteins specific to the compound made (modification of the compound or target) or multifunctional (efflux systems) are important systems. The resistance genes that are contiguous with the biosynthesis genes could be involved in regulation of the biosynthetic pathway.
There are consistent results  that showed that antibiotic resistance genes are found in natural sources. Another form of resistance in isolates not producing antibiotics is the mutation of the target gene product, which reduces or prevents inhibition by antibiotic binding. Spontaneous mutations causing resistance often lead to different bacterial phenotypes.
The presence of antibiotic resistance strains in environment may be understood as a response to the selective pressures. Thus, any antibiotic use will provide a selective pressure that perpetuates resistant bacteria. The introduction of antibiotics in the treatment of diseases that were prior incurable, enabled the effective treatment of these, promoting the increase in longevity. This kind of medicine is widely used in the treatment of people in the community and health services and is also used to treat animals in agricultural environments. Thus, the increasing levels of resistance are compromising the effectiveness of them. Therefore, it is essential that we assess the use of antibiotics carefully, regardless of setting, and use them only when necessary, to avoid promoting the development of resistance among bacteria .
Various infections are caused by important pathogens, such as
The food supply can be a source of antimicrobial-resistant and virulent
Interestingly, one outbreak happens, caused by one not expected
A relevant study involving enterotoxigenic
This event among others can prove how the versatility of this bacterium can reach a worldwide proportion, with a high concern for public health. These types of outbreaks are not solely a consequence of health conditions in developing countries. With the increase in international travel and trade globalization, diarrheagenic
On the other hand, antibiotic resistance rates in
This review shows the immune view of
2. Immune view
A good immune system is essential for the survival of any organism because of the protection against infectious beings. It is the principal infections evolution blocker that may cause elevated decease rate. This is a well-established fact for almost all known infective illness; the number of subjects in contact with the infectious agents is greater than those who really evolve diseases.
Contaminations occurred by no cell invasive bacteria are the most common. In these cases, the immune system of shield is mostly associated to the harborer’s innate barriers, natural protection mechanisms, and antibody production. The importance of innate barriers (Table 1) in the combat against no cell invasive bacterial infections is well-known . The integrity of skin and mucosa prevent adherence and penetration of bacteria; mucociliary movement eliminates bacteria from the respiratory tract; the stomach’s acidic pH destroys some bacteria penetrating by the upper digestive tract; and in the saliva, eyes secretion, and prostatic secretion, lysozyme and other substances have antimicrobial activity.
|I. Natural barriers against infection||II. Innate immunity||III. Acquired immunity|
|1. Integrity of skin and mucosa||1. Extracellular molecules (C reactive protein, complement)||1. Antibodies|
|2. Mucociliar movement||2. Natural killer cells, neutrophils, macrophages||2. Cytokines produced by T cells|
|3. pH variations||3. Chemokines, cytokines||–|
|4. Antimicrobial substances||–||–|
On the other hand, the main characteristic of intracellular bacteria is the ability to survive within the macrophages. In this context, some important pathogens are
Adaptive immunity, principally by means of antibodies plays an important function versus bacteria outside of the cell. Antibodies may exert its inhibition in three steps: (i) opsonization, (ii) activation of the complementary system, and (iii) furthering the neutralization of bacteria or their metabolites.
Extracellular bacteria are prone to undoing when phagocytozed. So subverting this system, they developed substances such as evasive mechanism with an antiphagocytic system.
Antibodies directed against these substances not only avoid their action, also facilitate phagocytosis, while neutrophils and macrophages have receivers for the fc part of immunoglobulin (opsonization).
The antibodies also coassist in the destruction of complement by bacteria, and activate this system by the classical pathway. Through neutralization mechanism, IgA antibodies, in particular, can bind to bacteria and therefore prevent the latter from settling on the intestinal mucosa and the respiratory tract. Antibodies bind frequently to toxins produced from bacteria, such as tetanus (
antibiotic resistance E. coli
A mature human gut harbors a vast number of bacterial resident microbiota, accounting for more than 1014 individual bacteria. Notably, the composition of the microbiota is individual host specific and the type of species living in the gastrointestinal tract varies with the host age, diet, habits, health, and idiosyncratic status . The intestinal mucosa is a first contact between the immune system and the external environment and plays a central role in a microbe and host cross talk . The indigenous intestinal microbiota provides important protective, metabolic and trophic functions, principally offering resistance to colonization by exogenous microorganisms, and preventing invasion by incoming pathogens.
The intestinal epithelium can resist against microbial invasion, but through evolution mechanisms, potential pathogenic enteric microorganisms developed strategies to circumvent and subvert this strong barrier. As an initial step in the infection process, some pathogens target specific epithelial cell structures, as glycoprotein and glycolipid , which act as receptors for attachment, permitting the microorganisms to exploit the underlying signal transduction pathway.
Other strategies utilized by invasive pathogens such as
The latter strategy can be done by direct cytotoxic injury, intracellular migration, disruption of the epithelial tight junctions, or indirectly by inducing neutrophil infiltration. Pathogenic
Enteric pathogens have the propriety to perturb the intestinal epithelial barrier and impact paracellular permeability, most often with an alteration in the arrangement of tight junctional component proteins by mechanisms that are unique for different pathogens. With respect to enteropathogenic
In one review about
In 2010, some authors  detected high resistance rates among
Also in 2010, one study  reported that morbidity and mortality attributable to third-generation-cephalosporin-resistant
Work with neonates in a single center concluded that the use of minor antibiotic therapy with reducing preemptive treatment resulted in a moderate reduction of the antibiotic use and did not increase mortality .
Another study  was conducted to determine the antimicrobial susceptibility patterns among common pathogens in the intensive care unit of a university hospital in Iran between 2006 and 2009. Authors worked with 606 isolates from respiratory, urine, blood, and wound specimens of 456 patients.
Scientists worked with 1163 clinical isolates in Taiwan . The frequencies of Gram-positive and Gram-negative bacteria isolates were 30.4 and 56.2%, respectively.
The antimicrobial resistance in one intensive care unit in Canada was investigated. In 2008, it was found high antibiotic rates to
According to a work conducted in 1975 , a hospital acquired urinary tract infection account for approximately 45% of nosocomial infection and 2–4% of the cases may develop septicemia. In this context, it was observed that 40% of the Gram-negative septicemia acquired in hospital originates in the urinary tract. This observation can enhance the
|Bacteria and fungi||Total||Resistance to all||Sensibility|
|N (%)||N (%)||N (%)|
|27 (49.1)||22 (81.5)||5 (18.5)|
|7 (12.7)||5 (71.4)||2 (28.6)|
|7 (12.7)||4 (57.1)||3 (42.9)|
|3 (5.5)||3 (100)||0|
|Others||5 (9.1)||2 (40)||3 (60)|
|Total||55 (100)||36 (73.5)||13 (26.5)|
4. Mechanisms of antibiotic resistance in Gram-negative bacteria
Bacterial antimicrobial resistance in both the medical and agricultural fields has become a serious problem worldwide. Resistant bacteria isolated from agriculture, farm or hospital can transfer the resistance genes to human pathogens . The selection pressure applied by the antibiotics that are used in clinical and agricultural settings has promoted the evolution and spread of genes that confer resistance, regardless of their origins. Several factors can be implicated with resistance, sensibility, and antibiotic resistance dissemination such as: (i) impermeable barriers ; in this case, some bacteria are intrinsically resistant to certain antibiotics because they have an impermeable membrane or lack the target of the antibiotic; (ii) multidrug resistance efflux pumps; these pumps protect the bacterial cell against toxic molecules. It is an active transport mechanism for outside the cell. Some transporters, such as those of the resistance-nodulation cell division family, can pump antibiotics directly outside the cell, whereas others, such as those of the major facilitator superfamily, secrete them into the bacterial periplasm; (iii) resistance mutations; these mutations can cause a modification in the target protein, for example, by disabling the antibiotic-binding without changing the protein functionality. Specific examples include mutations in the gyrase, which cause resistance to fluoroquinolones, in RNA polymerase subunit B, which cause resistance to rifampicin, and in the 30S ribosomal subunit protein S12 (encoded by
Cyclomodulins are a growing functional family of toxins, which hijack eukaryotic cell cycle. Four cyclomodulin types are actually known in
One interesting work  isolated ceftriaxone-resistant
5. Diarrheagenic and extra intestinal
pathotypes E. coli
Several distinct pathogenic categories (i.e., pathotypes or virotypes) of diarrheagenic
By definition, the virulence determinants of each
|Pathotype||Common genotype||Most common presentation||Intestinal pathology||Susceptibile groups|
|EPEC||eae +, bfp +, EAF +||Non-specific gastroenteritis, noninflammatory diarrhea||Intimate adhesion, attaching–effacing lesions throughout the intestine, loss of brush border enterocyte||Children under 2 years of age in developing countries|
|ETEC||LT, ST, (STa, STb toxins)||Watery, cholera-like diarrhea, noninflammatory diarrhea||No notable change, adhesion to small intestinal mucosa||Children in developing countries; travelers|
|EHEC||eae +, stx +||Bloody diarrhea ‘Hemorrhagic colitis’;||attaching–effacing lesions confined to the large intestine; necrosis in severe cases; HUS, hemorrhagic colitis||Children and the elderly in industrialized countries|
|EIEC||Inv||Bacillary dysentery||Inflammation and disruption of the mucosa, mostly of the large intestine; necrosis and blood loss||All ages; more common in less-developed countries|
|EAEC||AA +, aaa −/aaa +||Persistent diarrhea Inflammation;||cytotoxic changes in enterocytes||Children in less-developed countries; travelers to those countries|
|A-EPEC||eae +, bfp (−/+), EAF −||Nonspecific gastroenteritis||Some lesions throughout the intestine; toxin production as EAST1||Children and adults; reservoir for human infection|
It can be seen in Table 3, that the number of virulence traits varies from each pathotype and have implications on intestinal pathology. Besides Enteropathogenic
Based on genetic variation within
In one study, conducted in Ontario, Canada, the authors  showed that the most common bacteria identified on urine culture over a 5 year period were
Another study showed that resistance was more commonly seen in typical EPEC than in atypical pathotypes. The most prevalent resistances observed were to ampicillin, tetracycline, streptomycin, and the sulfonamides .
EPEC, an established etiological agent of human infantile diarrhea, is a pathogen that subverts intestinal epithelial cell function to produce distinctive “attaching and effacing” (A/E) lesions. These types of pathogens are typically found on the surface of the host epithelial cell. They can cause severe lesions on intestinal microvilli. Other pathogens can display similar characteristics, which includes
The interactions between EPEC and host cells have been divided into three stages. Initial adherence to cultured epithelial cells is mediated by the formation of type IV fimbriae known as bundle forming pili (BFP) . Initial adherence helps bring the bacteria in intimate contact with the host cell. BFPs mediate bacterial interactions in a human intestinal organ culture model .
The genetic answer for the formation of A/E lesions can be explained by the presence of the
The second stage of EPEC pathogenesis involves the secretion of bacterial proteins, some into the host cell, including EspA, EspB, and EspD at the temperature of the body , and particularly the gastrointestinal tract, the expression of these proteins is maximal, which implies that they may be involved in virulence. The translocation of these proteins is essential for activating a number of signal transduction pathways.
The third stage of EPEC interaction with the eukaryotic cells is characterized by the intimate attachment with the host cell. A 94-kDa outer membrane protein and intimin, encoded by the
Typical kinds of EPEC are EPECs that have lost the EAF plasmid. ETEC strains are a major cause of secretory diarrhea in both humans and animals. They produce heat-labile and/or heat-stable (STa and STb) toxins that also cause diarrhea. EHEC strains are implicated in foodborne diseases principally due to ingestion of uncooked minced meat and raw milk. These strains produce shiga-like toxin 1 (stx1), shiga-like toxin 2 (stx2), and variants thereof. These toxins can destroy colonic enterocytes and produce hemorrhagic colitis. EIEC can attach to enterocytes and penetrate by endocytosis and replicate therein. DAEC strains are diffusely adhering
Uropathogenic strains can invade bladder cells and at this local, form reservoirs, which is possibly the storage local of the bacterium.
Extended spectrum beta-lactamases (ESBLs) are the bacterial enzymes that make them resistant to advanced generation cephalosporins and might lead to the failure on therapy.
The importance of this resistance in one children population in India was studied. CTX-M-15 enzyme is increasingly being reported from this part of the world together with TEM-1 . TEM-1 is the most commonly encountered beta-lactamase in Gram-negative bacteria. Up to 90% of ampicillin, resistance in
Antimicrobial drug resistance is a large and growing problem among organisms that cause diarrheal disease. Although most diarrheal diseases are self-resolving and should not be treated with antimicrobial agents, invasive or protracted infections require chemotherapy and are typically managed empirically .
The more recently defined enteroaggregative
According some data [18, 20] about
In healthy populations, saprophytic microorganisms constitute a rich source of genetic material which pathogens can readily acquire resistance. The study conducted by NIS in Nigeria showed that resistance of commensal
Most antibiotic-producing strains carry genes encoding resistance to the antibiotics that they produce, and they are located in the same gene cluster as the antibiotic biosynthesis pathway genes. The sources by which antibiotic resistance genes can be found are presented in Table 4.
|Selection for antibiotic resistance||Environment||Utilization|
|Protection against endogenous antibiotics||Industrial antibiotic production||Utilization of antibiotics onto fields|
|Protection against naturally occurring antibiotics and heavy metals||Antibiotic consumption||Antibiotic consumption|
|Alternative cellular functions of the resistance protein||–||–|
|Physical forces||Biological forces||–|
|Air currents||Human activities||–|
Resistance genes exist naturally in the environment owing to a range of selective pressures in nature. Humans have applied additional selective pressure for antibiotic resistance genes because of the large quantities produced, consumed, and applied in daily activities. Physical and biological forces also cause widespread dissemination of resistance throughout many natural environments.
In lifetime, humans are exposed to antibiotic resistance bacteria. The potential routes for human exposition with wild animals and its microbiota include : (i) translocation of wildlife into suburban areas, habit destruction, pollution ,and changes to water storage, irrigation or climate changes; (ii) human contact with nature such as hunting and camping; (iii) consumption of exotic foods, bushmeat and game farms; (iv) acquisition of exotic pets and transport of live animals from long distances; (v) incorporation of animal’s habitats in human life as zoos; and (vi) trapping of fur-bearing animals.
Some microorganisms and some environments harbor antibiotic resistance genes irrespective of the human use of antibiotics. The prevalence and diversity of resistance genes in the environment inspire hypotheses about the native roles of so-called resistance genes in natural microbial communities.
6. Antibiotic resistance requires a coordinated response
Antibiotic use in animals has led to the emergence of resistant bacteria, and sometimes these resistant bacteria can be transferred from animals to humans by direct contact or by handling and/or consuming contaminated food.
High levels of resistance were observed for tetracycline as well as intermediate resistance against tetracycline, amikacin, and gentamicin. Gentamicin was the most effective out of these antibiotics . Some authors  have showed high rates of tetracycline resistance in strains of enteric
Unfortunately, infections caused by antibiotic resistant bacteria are an everyday occurrence in healthcare settings. In United States, an effort of the National Antimicrobial Resistance Monitoring System (NARMS) contributes to minimize the impact of resistance. NARMS consists in a lab-based system for surveillance. This system is presented in all 50 states and detects resistance in pathogens that are commonly transmitted from animals to humans or through food, such as
Another interesting goal to the process used to inhibit pathogens is linked to ancient knowledge. Many plant products are known to be able to inhibit the growth of several pathogens . These compounds are used by plants in defense mechanisms such as predation by herbivores, insects, and microbial infections.
On the other hand, some studies  have shown that microorganisms living in intimate interaction with the host plant without causing any apparent disease symptoms produce most of these compounds. These microorganisms are defined as endophytes .
Some studies  recently showed that the phytochemicals produced by endophytes have revolutionized the use of these microorganisms as a source of bioactive compounds in recent years . Among the great diversity of the different biomes, many plants stand out for its medicinal properties.
In another study ,
According to these data, the bioprospection of endophytes consists in a promising and unexplored reserve for phytochemical agents. Thus, there is a great opportunity to find new antimicrobial substances [64, 65].
7. Nanotechnology in health sciences
Nanotechnology is the technology that deals with materials and products at the nanoscale. It is able to provide more effective solutions to some of the biotechnology issues, such as the development of drugs, due to the reduction of the proportion between contact surfaces and volume of materials, optimizing their action and consequently reduces the consumption of substances and products.
Mesoporous nanostructures, as FDU-12 silica, have high specific surface area, mesoporous large volume, diameter, and adjustable pore surface properties that can be directed to the desired needs. They also have a great importance in catalysis processes, adsorption separation of large molecules, sensors, photonics, optical, drug release or drug, acoustic, nanoreactors, nanotechnology with advanced integrated systems, among others .
Lignin, besides being the second vegetal macromolecule found naturally in abundance, can functionalized mesoporous nanostructures, as it has in its structure phenolic and carboxylic groups. These groups are still capable of reducing metal to form nanoparticles and they also have the advantage coat of the silver nanoparticles.
8. Nanoparticles linked to silver
Metallic nanoparticles have different functions, like the following: (i) the marking of a particular stretch of DNA; (ii) the increase in resistance of metals and in the case of nanoparticles linked to silver; (iii) the antimicrobial action (both against Gram-negative bacteria, which have a thin layer of peptidoglycan and against Gram-positive, whose layer is thicker); and (iv) fungicide, which makes these particles a special nanostructured material to be incorporated into the control of such pathogens [72, 73].
However, there are no general consensuses about the mechanisms that can explain the action of silver nanoparticles in the inhibition of microbial growth. Some researchers claim that silver reacts with the thiol group of some vital enzymes to microorganisms and inactive them. Others claim dimerization of the pyrimidines of DNA, thus preventing the replication and thus their growth . Another hypothesis is that the silver nanoparticle causes a change in the cell membrane, causing the output of reducing sugars of the membrane and thus causing cell death .
A study conducted by Xu et al.  concluded that reactive oxygen species (ROS) played a very important role in the mechanism of AgNPs antibacterial activity, because in anaerobic conditions the efficiency was significantly lower.
Recently , α-Ag2WO4 microcrystals were synthetized and tested for antimicrobial activity against
It is known that silver is a toxic metal, for both humans at high concentrations, as for most microorganisms, it is the preferred substance for inhibition thereof, when compared to gold nanoparticles, zinc, and magnesium titanium .
The nanocomposites efficiency, containing silver, for the silver ion is much higher than the single metal species, as it has been proved in experiments . It is not completely understood yet, but it is believed that connecting silver to other nanoparticles, such as silica and lignin, can inhibit the growth of microorganisms and these nanoparticles contribute to the destabilizing effect of the cell membrane.
9. Bioactivity of propolis nanoparticles against
Propolis is a natural resinous substance collected from the leaf buds of different tree species by honeybees and known for its biological properties (antibacterial, antifungal, and antioxidant) .
Some authors  evaluated the antimicrobial activity of propolis nanoparticles in comparison with ethanol-propolis extract against
Antimicrobial activity of propolis nanoparticles and ethanol-propolis extract was tested against
The shown antimicrobial activity of propolis nanoparticles is of potential interest for direct applications or in film formulations, for example. Therefore, results obtained in this study, set the bases for future studies, using films as support for propolis nanoparticles, and for application in many products.
In the preantibiotic era , it was showed that from 30 lyophilized strains before 1950, four were multidrug resistant. The study of bacterial resistance can contribute to the discovery of the potential sources and novel alleles of antibiotic resistance genes. Considering that antibiotic treatment is our primary, and in many cases only, method of treating infectious diseases. We conclude that studies of environmental reservoirs of resistance are crucial to our future ability to fight infection. It is important to establish measures and politics to control the use of antibiotics, but an immediate modification of resistant profile in bacteria is not expected. Patients may follow procedures and use the antibiotics according prescription. The usual techniques of hand wash and use of barriers to prevent bacterial spread is important.
In the experiments, the FDU-12/silver nanoparticles showed the greatest inhibition in the growth of
Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037-1050.
Gangoue-Pieboji J, Eze N, Djintchui AN, Ngamenis B, Tsabangl N, Pegnyemb DE, et al. The in-vitro antimicrobial activity of some traditionally used medicinal plants against β-lactam-resistant bacteria. J Infect Dev Ctries. 2009; 3(9):671-680.
Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, et al. Inducible amp C beta-lactamase producing Gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis. 1997; 28: 211-219.
Jacoby TS, Kuchenbecker RS, Dos Santos RP, Magedanz L, Guzatto P, Moreira LB. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J Hosp Infect. 2010; 75(1): 23-27.
Kerwat K, Kerwat M, Graf J, Wulf H. Resistance to antibiotics and multiresistant pathogens. Anasthesiol Intensivmed Notfallmed Schmerzther. 2010; 45(4): 242-243.
Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol. 2010; 8(4): 251-259.
Aarestrup FM. Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic Clin Pharmacol Toxicol. 2005; 96: 271-281.
Rwego IB, Isabirye-Basuta G, Gillespie TR, Goldberg TL. Gastrointestinal bacterial transmission among humans, mountain gorillas, and livestock in Bwindi Impenetrable National Park, Uganda. Conserv Biol. 2008; 22: 1600-1607.
Sjolund M. et al. Dissemination of multidrug-resistant bacteria into the Arctic. Emerg Infect Dis. 2008; 14: 70-72.
Hall BG, Barlow M. Evolution of the serine β-lactamases: past, present and future. Drug Resist. Updat. 2004; 7: 111-123.
Frieden T. Antibiotic resistance and the threat to public health. Centers for Disease Control and Prevention. U.S. Department of Health and Human Services. CDC , Atlanta, US. 2010; 1-17.
Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum β-lactamase (ESBL)-producing Escherichia coli: importance of international travel. J Infect. 2008; 57: 441-448.
Palumbi SR. Humans as the world’s greatest evolutionary force. Science. 2001; 293: 1786-1790.
Johnson JR, McCabe JS, White DG, Johnston B, Kuskowski MA, Mcdermott P. Molecular analysis of Escherichia colifrom retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis. 2009; 49: 195-201.
Kwan CW, Onyett H. Community-acquired urinary tract pathogens and their resistance patterns in hospitalized children in southeastern Ontario between 2002 and 2006. Paediatr Child Health. 2008; 13(9): 759-762.
Scaletsky IC, Souza TB, Aranda KR, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli(EPEC) from Brazil. BMC Microbiol. 2010; 27: 10-25.
Roca RA, Sczancoski JC, Nogueira IC, Fabbro MT, Alves HC, Gracia L, et al. Facet-dependent photocatalytic and antibacterial properties of α-Ag2WO4 crystals: combining experimental data and theoretical insights. Catal. Sci. Technol. 2015; 5: 4091-4107.
Chattaway MA, Dallman T, Okeke IN, Wain J. Enteroaggregative E. coliO104 from an outbreak of HUS in Germany 2011, could it happen again?. J Infect Dev Ctries. 2011; 5(6): 425-436.
Nassour H, Dubreuil JD. Escherichia coliSTb enterotoxin dislodges claudin-1 from epithelial tight junctions. PLoS ONE. 2014; 9(11): e113273.
Rubino S, Cappuccinelli P, Kelvin DJ. Escherichia coli(STEC) serotype O104 outbreak causing haemolytic syndrome (HUS) in Germany and France. J Infect Dev Ctries. 2011; 5(6): 437-440.
Machado PRL, Araujo MIAS, Carvalho L, Carvalho EM. Mecanismos de resposta imune às infecções. Ann Bras Dermatol, Rio de Janeiro. 2004; 79(6): 647-664.
Hooper LV, Midwedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Ann Rev Nutr. 2002; 22: 283-307. DOI:10.1146/annurev.nutr.22.011602.092259.
Srikanth CV, Mccormick BA. Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip Perspect Infect Dis. 2008; 2008: 626827. Epub 2008; 1-14.
Schauer DB. Indigenous microflora: paving the way for pathogens?. Curr Biol. 1997; 7(2): R75–R77.
Galan JE, Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature. 2006; 444(7119): 567-573.
Benya RV, Marrero JA, Ostrovskiy DA, Koutsouris A, Hecht G. Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl− secretion. Am J Physiol. 1999; 276(1): G64–G72.
Yuha R, Koutsouris A, Savkovlc SD, Hecht G. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology. 1997; 113(6): 1873-1882.
Benz I, Schmidt MA. Cloning and expression of an adhesin (AIDA-I) involved in diffuse adhrence of enteropathogenic I. Infect Immunity. 1989; 57: 1506-1511.
Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceaeproducing extended-spectrum β-lactmases (ESBLs) in the community. J Antimicrob Chemother. 2005; 56: 52-59.
Livermore DM, Woodford N. The ß-Lactamase Threat in Enterobacteriaceae, Pseudomonasand Acinetobacter. Trends Microbiol. 2006; 14: 413-420.
Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coliand Salmonella: recent developments. Int J Antimicrob Agents. 2005; 25: 358-373.
Dubreuil JD. STb and AIDA-I: the missing link? Crit Rev Microbiol. 2010; 36(3): 212-220.
Kmet V, Piatnicová E. Antibiotic resistance in commensal intestinal microflora. Folia Microbiol. 2010; 55(4): 332-335.
De Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coliresistant to third-generation cephalosporins. J Antimicrob Chemother. 2010; 66(2):398-407.
Zingg W, Pfister R, Posfay-Barbe KM, Huttner B, Touveneau S, Pittet D. Secular trends in antibiotic use among neonates: 2001-2008. Pediatr Infect Dis J. 2011; 30(5):365-370.
Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Surveillance of antimicrobial susceptibility among bacterial isolates from Intensive Care Unit patients of a Tertiary-Care University Hospital in Iran: 2006-2009. Chemotherapy. Nov 23, 2010; 56(6): 478-484.
Lee CY, Chen PY, Huang FL, Lin CF. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center—6 years' experience. J Microbiol Immunol Infect. 2009; 42(2): 160-165.
Zhanel GG, Decorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, et al. Canadian antimicrobial resistance alliance (CARA), Hoban DJ. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother. 2008 Apr; 52(4): 1430-1437.
Kamat US, Fereirra A, Amonkar D, Motghare DD, Kulkarni MS. Epidemiology of hospital acquired urinary tract infections in a medical college hospital in Goa. Indian J. Urology. 2009; 25(1): 76-80.
Rhodes G, et al. Distribution of oxytetracycline resistance plasmids between aeromonads in hospital and aquaculture environments: implication of Tn1721 in dissemination of the tetracycline resistance determinant Tet A. Appl. Environ. Microbiol. 2000; 66: 3883-3890.
Uma B, Prabhakar K, Rajendran S, Kavitha K, Sarayu YL. Antibiotic sensitivity and plasmid profiles of Escherichia coliisolated from pediatric diarrhea. J Glob Infect Dis. July 2009; 1(2): 107-110.
Krueger AL, Folster J, Medalla F, Joyce K, Perri MB, Johnson L, et al. Commensal Escherichia coliisolate resistant to eight classes of antimicrobial agents in the United States. Foodborne Pathog Dis. Feb 2011; 8(2): 329-332.
Lindsey RL, Fedorka-Cray PJ, Frye JG, Meinersmann RJ. Inc A=C plasmids are prevalent in multidrug-resistant Salmonella entericaisolates. Appl Environ Microbiol. 2009; 75: 1908-1915.
Robins-Browne RM, Hartland EL. Escherichia colias a cause of diarrhea. J Gastroenterol Hepatol. 2002; 17: 467-475.
Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, et al. Sex and virulence in E. coli: an evolutionary perspective. Mol Microbiol. 2006; 60(5): 1136-1151.
Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Ann Rev Microbiol. 2000; 54: 641-679.
Giron JA, Ho AS, Schoolnik GK. An inducible bundleforming pilus of enteropathogenic Escherichia coli. Science. 1991; 254: 710-713.
Hicks S, Frankel G, Kaper J, Dougan G, Philips AD. Role of intimin and bundle-forming pili in enteropathogenic Escherichia coliadhesion to pediatric intestinal tissue in vivo. Infect Immun. 1998; 66: 1570-1578.
McDaniel TK, Kaper JB. A cloned pathogenicity island from enteropathogenic Escherichia coliconfers the attaching and effacing phenotype on E. coliK-12. Mol Microbiol. 1997; 23: 399-407.
Kenny B, Abe A, Stein M, Finlay BB. Enteropathogenic Escherichia coliprotein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect Immun. 1997; 65: 2606-2612.
Jerse AE, Kaper JB. The eaegene of enteropathogenic Escherichia coliencodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect Immun. 1991; 59: 4302-4309.
Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis. 2007;4(2): 134-163.
Sousa CP. The versatile strategies of Escherichia colipathotypes: a mini review. J Venom Animals Toxins Including Tropical Dis. 2006; 12: 363-373.
Johnson JR, Kuskowski MA, Smith K, O'Bryan TT, Tatini S. Antimicrobial-resistant and extraintestinal pathogenic Escherichia coliin retail foods. J Infect Dis. April 1, 2005; 191(7): 1040-1049.
Shakil S, Akram M, Ali SM, Khan AU. Acquisition of extended-spectrum β-lactamase producing Escherichia colistrains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J Med Microbiol. 2010; 59: 948-954.
Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet Infect Dis. 2001; 1: 304-313.
Gassama A, Sow PS, Fall F, Camara P, Gueye-N’diaye A, Seng R, et al. Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to a human immunodeficiency virus serostatus. Int J Infect Dis. 2001; 5: 192-198.
Marcon MJ, Kiska DL, Riddell SW, Gilligan P. Should all stools be screened for shiga toxin-producing Escherichia coli?. J. Clin. Microbiol. Jul 2011; 49: 2390-2397.
Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB, Nataro JP. Heterogeneous virulence of enteroaggregative Escherichia colistrains isolated from children in southwest Nigeria. J Infect Dis. 2000; 181: 252-260.
Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, Stobberingh EE. Antibiotic resistance of fecal Escherichia colifrom healthy volunteers from eight developing countries. J Antimicrob Chemother. 2004; 54: 952-955.
Garcia PG, Silva VL, Diniz CG. Occurrence and antimicrobial drug susceptibility patterns of commensal and diarrheagenic E. coliin fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011; 49(1): 46-52.
Usein CR, Taty-Chitoiu D, Ciontea S, Condei M, Damian M. Escherichia colipathotypes associated with diarrhea in Romanian children younger than 5 years of age. J. Infect. Dis. 2009; 62: 289-293.
Roberts RR, Hota B, Ahmad I, Scott RD II, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 2009; 49: 1175-84.
Dubreuil JD. Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli. Toxins. 2013; 5: 2009-2041.
Lacava PT, Sousa CP. Role of endophytic actinomycetes in crop protection: plant growth promotion and biological control. Plant Growth Promoting Actinobacteria. 1ed.Telangana, India: Springer Singapore. 2016; 1: 147-160.
Ratti RP, Piza ACMT, Malpass AC, Hokka CO, Dubreuil JD, Sousa CP. Growing kinetics and antimicrobial activity of Streptomyces tubercidicus crude extracts. In: World Scientific Publishing Company Pte Ltd. (Org.). Microorganisms in Industry and Environment from scientific and industrial research to consumer products. Singapore: World Scientific Publishing Company Pte Ltd. 2010; 1: 589-592.
Serrano NFG. Purificação e caracterização bioquímica de substâncias bioativas produzidas por endofítico isolado de Prunusspp. Dissertation, Federal University of São Carlos, Sao Carlos, Sao Paulo, Brazil. 2009.
Serrano NFG, Rodrigues LRM, Hokka CO, Sousa CP, Teixeira JAC, Mussato SID. Optimal glucose and inoculum concentrations for production of bioactive molecules by Paenibacillus polymyxaRNC-D. Chem Papers (Online). 2012; 66: 1111-1117.
Piza ACMT, Hokka CO, Sousa CP. Endophytic actinomycetes from Miconia albicans(Sw.) Triana (Melastomataceae) and evaluation of its antimicrobial activity. J Sci Res Reports. 2015; 4: 281-291.
Piza ACMT, Lima LCPS, Hokka CO, Sousa CP. Endophytic Nocardiopsis dassonvilleiand Amycolatopsis orientalisisolated from Brazilian tropical savannah presented antibiosis against pathogens. In: A. Méndez-Vilas. (Org.). Microbes in the spotlight: recent progress in the understanding of beneficial and harmful microorganisms. 1st ed. Boca Raton: BrownWalker Press. 2016; 1: 264-266.
Lu J, et al. Ultrasensitive electrochemical immunosensor based on Au nanoparticles dotted carbon nanotube-graphene composite and functionalized mesoporous materials. Biosens Bioelectron. 2012; 33: 29-35.
Klabunde KJ. Richards RM (Ed). Nanoscale materials in chemistry, Wiley. 2nd ed. 2009; 804 p.
Morones JR, et al. The bactericidal effect of silver nanoparticles. Nanotechnology, Institute of Physics Publishing. 2005; 16: 2346-2353.
Matsumura Y, et al. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol Am Soc Microbiol. 2003; 69(7): 4278-4281.
Li J, et al. Highly selective antibacterial activities of silver nanoparticles against bacillus subtilis. J Nanosci Nanotechnol. 2013; 13(10): 6806-6813.
Xu H, Qu F, Xu H, Lai W, Andrew Wang Y, Aguilar ZP, et al. Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on Escherichia coliO157:H7. Biometals. Feb 2012; 25(1): 45-53.
Roca RA, Gouveia AF, Lemos PS, Gracia L, Andrés J, Longo E. Formation of ag nanoparticles on β-ag2wo4 through electron beam irradiation: a synergetic computational and experimental study. Inorg Chem. Aug 17, 2016; 55: 8661-8671.
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009; 27: 76-83.
Koo H, Gomes BPFA, Rosalen PL, Ambrosano GMB, Park YK, Cury JA. In vitroantimicrobial activity of propolis and Arnica montanaagainst oral pathogens. Arch Oral Biol. 2000; 45: 141-148.
Alves HC, et al. Antimicrobial activity of propolis nanoparticles against some common meat contamination bacteria. Food Microbiology & Biotechnology, Portuguese Congress of Microbiology and Biotechnology. 2013; 44.
Smith DH. R factor infection of E. colilyophilized in 1946. J Bacteriol. 1967; 94: 2071-2072.